These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6721985)

  • 21. Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.
    Nichols AI; Jusko WJ
    J Pharmacokinet Biopharm; 1990 Jun; 18(3):189-208. PubMed ID: 1974305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose dependent pharmacokinetics of prednisolone.
    Pickup ME; Lowe JR; Leatham PA; Rhind VM; Wright V; Downie WW
    Eur J Clin Pharmacol; 1977 Nov; 12(3):213-9. PubMed ID: 590308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate.
    Chen MF; Shimada F; Kato H; Yano S; Kanaoka M
    Endocrinol Jpn; 1990 Jun; 37(3):331-41. PubMed ID: 2253583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution of prednisolone in the rabbit.
    Khalafallah N; Jusko WJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of prednisolone in adrenal insufficiency ].
    von Papen C; Benker G; Hackenberg K; Reinwein D
    Klin Wochenschr; 1982 Jul; 60(13):681-6. PubMed ID: 7120877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose.
    McAllister WA; Winfield CR; Collins JV
    Eur J Clin Pharmacol; 1981; 20(2):141-5. PubMed ID: 7262175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants.
    Gambertoglio JG; Holford NH; Kapusnik JE; Nishikawa R; Saltiel M; Stanik-Lizak P; Birnbaum JL; Hau T; Amend WJ
    Kidney Int; 1984 Jan; 25(1):119-23. PubMed ID: 6374250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.
    Wald JA; Law RM; Ludwig EA; Sloan RR; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Dec; 20(6):567-89. PubMed ID: 1302763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prednisolone clearance at steady state in dogs.
    Frey FJ; Frey BM; Greither A; Benet LZ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):287-91. PubMed ID: 7441495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring prednisone and prednisolone.
    Jusko WJ; Rose JQ
    Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
    Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
    Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal handling of prednisolone/prednisone: effect of steroid dose and 11 beta-hydroxysteroid dehydrogenase.
    Conti M; Frey FJ; Escher G; Marone C; Frey BM
    Nephrol Dial Transplant; 1994; 9(11):1622-8. PubMed ID: 7870352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of plasma prednisolone in man.
    Wilson CG; Ssendagire R; May CS; Paterson JW
    Br J Clin Pharmacol; 1975 Aug; 2(4):321-5. PubMed ID: 1233991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.
    Frey FJ; Gambertoglio JG; Frey BM; Benet LZ; Amend WJ
    Eur J Clin Pharmacol; 1982; 23(1):65-74. PubMed ID: 6751835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
    Frey FJ; Horber FF; Frey BM
    Clin Pharmacol Ther; 1988 Nov; 44(5):510-21. PubMed ID: 2972434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.
    Bergrem H; Grøttum P; Rugstad HE
    Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives.
    Olivesi A
    Biomed Pharmacother; 1986; 40(8):301-8. PubMed ID: 3814762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.